New drug candidate developed for the treatment of type 2 diabetes, Gütsel Online, OWL live & More Latest News Here

New drug candidate developed for the treatment of type 2 diabetes

Researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormonal combination for the future treatment of type 2 diabetes. #Scientists have combined the hypoglycemic effects of the drug Tesaglitazar and GLP 1 hormone in a new highly effective active ingredient. When combined with GLP 1, the new molecule only reaches tissues containing the GLP 1 receptor. This reduces the side effects of Tesaglitazar and increases the effects on sugar metabolism. The new active ingredient has already been successfully tested in animal models. The results have now been published in »Nature Metabolism«.

The active ingredient #Tesaglitazar improves glucose and lipid metabolism in patients with type 2 diabetes. It activates 2 receptors in the cell nucleus and thus improves insulin sensitivity. This has been shown in phase 3 clinical studies. However, Tesaglitazar also had some unwanted side effects, such as signs of kidney damage. In order to be able to use the active ingredient for therapeutic purposes, the researchers used a trick: they biochemically bound it to the gastrointestinal hormone GLP 1, which has been used successfully for the treatment of type 2 diabetes for several years. In this way, the combined drug can only be introduced into cells and tissues that possess the GLP 1 receptor. “With this trick, we have managed to combine the hypoglycemic effects of GLP 1 and tesaglitazar into a single, highly effective molecule. while keeping tesaglitazar away from the tissues in which it has harmful effects”, explains the author. study leader, PD Dr. Timo Müller, Director of the Diabetes and #Adiposity Institute and DZD scientist.

The new active ingredient improved glucose tolerance and therefore #sugar metabolism

The new #active has already been successfully tested in an animal model: “In obese and diabetic male mice, it improves sugar metabolism significantly more than treatment with the individual hormones GLP 1 or tesaglitazar alone – and that without side effects harmful to the liver or kidneys,” explains Professor Kerstin Stemmer, one of the first authors of the study. The active ingredient increased glucose tolerance particularly effectively. Minimal doses of the new active ingredient are sufficient to sustainably improve blood sugar metabolism. “The active ingredient could have great potential for the acute treatment of high blood sugar levels in type 2 diabetes,” says Aaron Novikoff, also the first author of the study.

Next, the researchers now want to investigate whether this active ingredient also has potential to treat type 2 diabetes in humans, and whether the effectiveness of this new combination therapy can be further optimized by additional biochemical modification.


A team led by Prof. Dr Matthias Tschöp (Scientific Director Helmholtz Munich) and Dr Timo Mueller as well as Richard DiMarchi, Ph.D. (Indiana University) and Dr Brian Finan (Novo Nordisk) have been working for years on new drug candidates for the treatment of type 2 diabetes and obesity. So-called polyagonists simultaneously mimic the effects of various hormones. In clinical studies, some of these polyagonists have shown great promise for improving the treatment of obesity and type 2 diabetes and are currently undergoing phase 2 and 3 clinical studies. dual agonists for the treatment of type 2 diabetes was approved in the United States this year. The drug combines GLP 1 and GIP (glucose-dependent peptide) receptor agonists that mimic the two gut hormones, GLP 1 and GIP.

New drug candidate developed for the treatment of type 2 diabetes, Gütsel Online, OWL live
& Latest News Update

I tried to give all kinds of news to y’all latest news today 2022 through this site and you will like all this news very much because all the news that we always give in this news is always there. It’s on a trending topic and regardless of the latest news

it was always our effort to reach you that you continue to get the Electricity News, Degree News, Donation News, Bitcoin News, Trade News, Real Estate News, Gaming News, Trending News, Digital Marketing, Telecom News, Beauty News, Banking News, Travel News, Health New, Cryptocurrency News, Claims News the latest news and you always keep getting the news information for free through us and also tell people. Give that any information related to other types of news will be

New drug candidate developed for the treatment of type 2 diabetes, Gütsel Online, OWL live
and more live news

All this news I made and shared for you, you will like it very much and we keep bringing you topics like every time so you keep getting hot news like trending topics and you It’s our goal to be able to have

all kinds of news without going through us so that we can reach you the latest and best news for free so that you can go further by getting the information of this news with you. Later we will continue

to provide information on more world news update today types of latest news through posts on our website so that you always keep moving forward in this news and whatever type of information will be there, it will definitely be passed on to you.

New drug candidate developed for the treatment of type 2 diabetes, Gütsel Online, OWL live
and more news today

All this news that I have brought you or will be the most different and best news that you will not get anywhere, as well as the information Trending News, Latest News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, World News of this made available to you all so that you are always connected with the news, stay ahead of the game and continue to today’s news all types of news for free till today so you can get the news by getting it. Always take two steps forward

Credit goes to news website – This news website from the original content owner. This is not my content so if you want to read the original content you can follow the links below

Get original links here🡽

Comments are closed.